ChiCTR2000028765
结束
/
/
/
2020-01-02
/
/
Proximal femoral fracture
Reverse oblique intertrochanteric fractures fixation
Proximal femoral locking compression plate: Better fracture reduction quality and similar functional results compared to long proximal femoral nail antirotation in fixation of reverse oblique intertrochanteric fractures
The aim of this study was to compare the clinical and radiological results of long proximal femoral nail antirotation (LPFNA) with proximal femoral locking compression plate (PFLCP) in fixation of reverse oblique fractures.
非随机对照试验
回顾性研究
No
No
we have not any funding
/
35;27
/
2018-11-25
2019-02-25
/
Our inclusion criteria were; age over 18 who has no deformity and previus fracture with same extremity；
请登录查看Our exclusion criteria were as follow: age <18 years, AO/OTA 31A1 and 31A2 fractures, fractures that extended 10 cm distal to the level of the lesser trochanter, bilateral hip fracture, pathologic fractures, another fracture in the extremities or spine, open fractures, history of lower limb fracture or deformity, previous ipsilateral lower limb surgery, contralateral hip fracture within the last year, cognitive impairment, severe concomitant medical condition (Grade V American Society of Anesthesiologists [ASA] score) [12]. death during follow-up, reoperation requirements due to mechanical complications, and a follow-up period of <1 year.；
请登录查看Orthopaedics and taumatology clinic (MD MEHMET ALI TALMAC)
/
Orthopaedics and taumatology clinic (MD MEHMET ALI TALMAC)的其他临床试验
土耳其伊斯坦布尔锡斯利哈米迪耶埃法尔医院的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04